Composition, form of production and packaging
The solution for infusions is transparent, from colorless to light yellow color.
dextrose 50 g
Sodium Chloride 5.26 g
sodium gluconate 5.02 g
Sodium acetate 3.68 g
potassium chloride 370 mg
magnesium chloride 300 mg
Ionic composition: sodium - 140 mmol / L Potassium - 5 mmol / L Magnesium - 1.5 mmol / L chloride - 98 mmol / L Acetate - 27 mmol / L Gluconate - 23 mmol / l
500 ml - plastic containers "Vifaflex" (1) - plastic bags (20) - cardboard boxes.
1 l - plastic containers "Vifaflex" (1) - plastic bags (10) - cardboard boxes.
500 ml - plastic containers "Viaflo" (1) - plastic bags (20) - cardboard boxes.
1 L - plastic containers "VIAFLO" (1) - plastic bags (10) - cardboard boxes.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
Plasma-Lit 148 with 5% glucose corrects the acid-base state, replenishes the deficiency of fluid and electrolytes, increases diuresis, has an antiaggregant property, reduces metabolic acidosis, improves microcirculation, exerts detoxification, anti-shocks.
Glucose increases oxidation-reduction processes in the body, covers part of the energy expenditure of the body, tk. is a source of easily assimilated carbohydrates. With the metabolism of glucose in tissues, a significant amount of energy is released, which is necessary for the vital functions of the organism.
Plasma-Lit 148 with 5% glucose is used in adults and children as a component of infusion therapy:
- with complex treatment of shock;
- with thermal injury;
- with acute blood loss;
- hypotonic and isotonic forms of hypohydration;
- with metabolic acidosis in severe patients;
- for correction of water-salt balance;
- with acute diffuse peritonitis and intestinal obstruction;
- for the treatment of patients with intestinal fistula;
- at decompensation of electrolyte disturbances;
- in patients with acute intestinal infections;
- with dehydration and metabolic acidosis;
The volemic effect of the drug is short, in the treatment of severe hypovolemia, a combination with colloidal solutions as well as blood and its components is recommended.
The drug is used under the control of laboratory studies.
Apply intravenously (struyno and drip). Before administration, the solution is warmed to body temperature.
The daily dose for adults - 5-20 ml / kg, if necessary, can be increased to 30-40 ml / kg. Entering at a speed of 60-80 drops / min, an inkjet injection is allowed. The daily dose for children is 5-10 ml / kg, the rate of administration is 30-60 drops / min. The course of treatment is 3-5 days.
Perhaps the development of hyperkalemia.
There may be venous irritation and thrombophlebitis at the injection site.
- hypertonic dehydration;
Contraindicated in the introduction of large volumes of fluid.
APPLICATION FOR FUNCTIONS OF THE LIVER
In patients with renal insufficiency, it is necessary to monitor the level of electrolytes in the plasma.
APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS
In patients with hepatic insufficiency, it is necessary to monitor the level of electrolytes in the plasma.
APPLICATION FOR CHILDREN
The daily dose for children is 5-10 ml / kg, the rate of administration is 30-60 drops / min. The course of treatment is 3-5 days.
In patients with renal, cardiac or liver failure, it is necessary to monitor the level of electrolytes in the plasma.
It is recommended to replace all devices for IV infusion at least 1 time / day.
A careful and aseptic mixing of additional substances is necessary. After mixing, the solution, if not injected immediately, should be stored at a temperature of 2 В° to 8 В° C for 24 hours.
Do not inject a cloudy solution or from a damaged container.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription. For health care institutions.
TERMS AND CONDITIONS OF STORAGE
Keep out of the reach of children at a temperature of up to 25 В° C. Do not freeze. Shelf life - 2 years. The drug should be used before the date indicated on the package.